Survivin and IAP proteins in cell-death mechanisms

DC Altieri - Biochemical Journal, 2010 - portlandpress.com
From the realization that cell number homoeostasis is fundamental to the biology of all
metazoans, and that deregulation of this process leads to human diseases, enormous …

[HTML][HTML] Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue …

F Li, T Jiang, Q Li, X Ling - American journal of cancer research, 2017 - ncbi.nlm.nih.gov
Camptothecin (CPT) was discovered from plant extracts more than 60 years ago. Since then,
only two CPT analogues (irinotecan and topotecan) have been approved for cancer …

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression

M Zhou, Z Liu, Y Zhao, Y Ding, H Liu, Y Xi… - Journal of Biological …, 2010 - ASBMB
Paclitaxel (Taxol) is an effective chemotherapeutic agent for treatment of cancer patients.
Despite impressive initial clinical responses, the majority of patients eventually develop …

Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol

M Zhou, Y Zhao, Y Ding, H Liu, Z Liu, O Fodstad… - Molecular cancer, 2010 - Springer
Background Taxol is one of the most effective chemotherapeutic agents for the treatment of
patients with breast cancer. Despite impressive clinical responses initially, the majority of …

Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth

YH Zhao, M Zhou, H Liu, Y Ding, HT Khong, D Yu… - Oncogene, 2009 - nature.com
ErbB2 has been shown to activate signaling molecules that may regulate glucose
metabolism. However, there is no evidence reported to directly link ErbB2 to glycolysis, and …

Resistance to intervention: paclitaxel in breast cancer

VM Dan, RS Raveendran… - Mini Reviews in Medicinal …, 2021 - ingentaconnect.com
Breast cancer stands as the most prevalent cancer in women globally, and contributes to the
highest percentage of mortality due to cancer-related deaths in women. Paclitaxel (PTX) is …

Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling

X Peng, F Gong, Y Chen, Y Jiang, J Liu, M Yu… - Cell death & …, 2014 - nature.com
Paclitaxel is one of the most effective chemotherapy drugs for advanced cervical cancer.
However, acquired resistance of paclitaxel represents a major barrier to successful …

[HTML][HTML] Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

SN Dorman, K Baranova, JHM Knoll, BL Urquhart… - Molecular …, 2016 - Elsevier
Increasingly, the effectiveness of adjuvant chemotherapy agents for breast cancer has been
related to changes in the genomic profile of tumors. We investigated correspondence …

Current therapies for human epidermal growth factor receptor 2-positive metastatic breast cancer patients

AA Larionov - Frontiers in oncology, 2018 - frontiersin.org
The median survival of patients with human epidermal growth factor receptor 2 (HER2)-
positive metastatic breast cancer (MBC) has more than doubled, since the discovery of …

B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation

H Liu, C Tekle, YW Chen, A Kristian, Y Zhao… - Molecular cancer …, 2011 - AACR
In many types of cancer, the expression of the immunoregulatory protein B7-H3 has been
associated with poor prognosis. Previously, we observed a link between B7-H3 and tumor …